Michael Majores
Sigmund Freud Str. 25
Bonn, NW 53127, Germany
Bonn, NW 53127, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A case of Rowell syndrome after a herpes simplex infection and prolonged sun exposure.
Journal: Skin health and disease
Published: November 25, 2023
Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer.
Journal: Journal of cancer research and clinical oncology
Published: August 23, 2023
CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients.
Journal: Epigenetics
Published: October 01, 2016
PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies.
Journal: The Journal of molecular diagnostics : JMD
Published: June 24, 2016
Nodular eyelid margin and lip tumors without MEN2b syndrome in a 29 year old man
Journal: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
Published: April 02, 2016
Actinic keratosis: correlation between clinical and histological classification systems.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 18, 2015
The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 21, 2015
Membranous CD24 expression as detected by the monoclonal antibody SWA11 is a prognostic marker in non-small cell lung cancer patients.
Journal: BMC clinical pathology
Published: March 27, 2015
Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin
Journal: Der Pathologe
Published: February 10, 2015
Lysine-specific demethylase 1 (LSD1) in hematopoietic and lymphoid neoplasms.
Journal: Blood
Published: July 05, 2014
KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomy.
Journal: The American journal of pathology
Published: March 14, 2014
Last Updated: 09/26/2026